UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | C | D | G | H | L | P | R | S | V | W | Z
Number of items: 14.


Ahlskog, JKJ; Schliemann, C; Marlind, J; Qureshi, U; Ammar, A; Pedley, RB; Neri, D; (2009) Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours. BRIT J CANCER , 101 (4) 645 - 657. 10.1038/sj.bjc.6605200.


Chua, YL; Ito, Y; Pole, JCM; Newman, S; Chin, S-F; Stein, RC; Ellis, IO; (2009) The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene. ONCOGENE , 28 (46) pp. 4041-4052. 10.1038/onc.2009.259.


Dancey, G; Violet, J; Malaroda, A; Green, AJ; Sharma, SK; Francis, R; Othman, S; (2009) A Phase I Clinical Trial of CHT-25 a I-131-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma. CLIN CANCER RES , 15 (24) 7701 - 7710. 10.1158/1078-0432.CCR-09-1421.


Giampieri, S; Manning, C; Hooper, S; Jones, L; Hill, CS; Sahai, E; (2009) Localized and reversible TGF beta signalling switches breast cancer cells from cohesive to single cell motility. NAT CELL BIOL , 11 (11) 1287 - U49. 10.1038/ncb1973.

Gibson, F; Aldiss, S; Taylor, RM; Maguire, R; Kearney, N; (2009) Involving health professionals in the development of an advanced symptom management system for young people: The ASyMS (c)-YG study. EUR J ONCOL NURS , 13 (3) 187 - 192. 10.1016/j.ejon.2009.03.004.


Hochhauser, D; Meyer, T; Spanswick, VJ; Wu, J; Clingen, PH; Loadman, P; Cobb, M; (2009) Phase I Study of Sequence-Selective Minor Groove DNA Binding Agent SJG-136 in Patients with Advanced Solid Tumors. CLIN CANCER RES , 15 (6) 2140 - 2147. 10.1158/1078-0432.CCR-08-1315.


Lee, SM; James, LE; Qian, W; Spiro, S; Eisen, T; Gower, NH; Ferry, DR; (2009) Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer. THORAX , 64 (1) pp. 75-80. 10.1136/thx.2007.093872.

Loddo, M; Kingsbury, SR; Rashid, M; Proctor, I; Holt, C; Young, J; El-Sheikh, S; (2009) Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer. BRIT J CANCER , 100 (6) 959 - 970. 10.1038/sj.bjc.6604924.


Plummer, R; Vidal, L; Griffin, M; Lesley, M; de Bono, J; Coulthard, S; Sludden, J; (2009) Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors. CLIN CANCER RES , 15 (9) 3177 - 3183. 10.1158/1078-0432.CCR-08-2859.


Razak, ARA; Nutt, JE; O'Toole, K; Black, F; Plummer, ER; Calvert, AH; Lunec, J; (2009) Expression of folate receptor alpha (FRa) in malignant pleural mesothelioma patients by immunohistochemistry: a clinico-pathological analysis. Lung Cancer , 63 82 - ?.


Seymour, LW; Ferry, DR; Kerr, DJ; Rea, D; Whitlock, M; Poyner, R; Boivin, C; (2009) Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer. INT J ONCOL , 34 (6) 1629 - 1636. 10.3892/ijo_00000293.


Valle, JW; Wasan, H; Johnson, P; Jones, E; Dixon, L; Swindell, R; Baka, S; (2009) Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01. British Journal of Cancer , 101 (4) 621 - 627.


Windsor, R; Strauss, S; Seddon, B; Whelan, J; (2009) Experimental therapies in Ewing’s sarcoma. Expert Opin Investig Drugs , 18 , Article 2.


Zhang, EZ; Laufer, JG; Pedley, RB; Beard, PC; (2009) In vivo high-resolution 3D photoacoustic imaging of superficial vascular anatomy. PHYS MED BIOL , 54 (4) 1035 - 1046. 10.1088/0031-9155/54/4/014.

This list was generated on Sun Oct 23 03:29:45 2016 BST.